| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/20/2005 | CN1642950A 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642945A Stable hydrate of a muscarinic receptor antagonist |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642941A 1-N-aminobenzimidazole derivatives |
| 07/20/2005 | CN1642934A Production of delta9 tetrahydrocannabinol |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642904A Salts of nateglinide |
| 07/20/2005 | CN1642902A Polyamine compounds and compositions for use in conjunction with cancer therapy |
| 07/20/2005 | CN1642568A Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642565A Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 07/20/2005 | CN1642561A Compositions containing labile bioactive materials, methods of preparation and treatment |
| 07/20/2005 | CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 07/20/2005 | CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642550A Beta-sheet mimetics and composition and methods relating thereto |
| 07/20/2005 | CN1642542A Angiogenesis inhibitors |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1642437A Probiotic delivery system |
| 07/20/2005 | CN1640485A Use of selaginella tamariscina for preparing medicine for treating gastrosia and its Chinese medicine composition |
| 07/20/2005 | CN1640482A Pure Chinese medicine preparation for parodontium anaesthesia and its preparing process |
| 07/20/2005 | CN1640478A External-use Chinese medicine preparation for treating anal-intestinal disorder and its preparing method |
| 07/20/2005 | CN1640474A Hepatic calculus dissolving solution |
| 07/20/2005 | CN1640469A Oral sterilizing tablet |
| 07/20/2005 | CN1640466A Method for preparing oral liquor of monkshood for regulating functions of stomach and spleen |
| 07/20/2005 | CN1640464A Oral deodorizing drink |
| 07/20/2005 | CN1640458A Navel-moistening health-care liquor |
| 07/20/2005 | CN1640457A Chinese medicine composition for treating viral hepatitis B |
| 07/20/2005 | CN1640448A Stagnated hepatoqi dispersing medicine for preventing and treating SARS and viral hepatitis complication |
| 07/20/2005 | CN1640445A Fresh eucommia leaf preparation and its preparing method |
| 07/20/2005 | CN1640442A Fresh multiflower knotweed tuber preparation and its preparing method |
| 07/20/2005 | CN1640439A Method for preparing oral tablet |
| 07/20/2005 | CN1640437A Medicinal composition for treating gastro intestinal tract disease |
| 07/20/2005 | CN1640433A Stomach-nourishing soft capsule and its preparing process |
| 07/20/2005 | CN1640429A Method for extracting effective component from sophora alopecuroide for reducing blood fat and its medicinal use |
| 07/20/2005 | CN1640428A One-time-clearing soft capsule and its preparing process |
| 07/20/2005 | CN1640426A Biological energy reinforced agent-sheep kidney concentrated liquor |
| 07/20/2005 | CN1640415A Medicine for treating diarrhoea in children and its preparation |
| 07/20/2005 | CN1640413A Pearl nourishing health-care vinegar oral liquid and its preparing method |
| 07/20/2005 | CN1640412A 西地碘口含片 West to iodine buccal tablets |
| 07/20/2005 | CN1640411A Matched reagent for removing tooth decay |
| 07/20/2005 | CN1640408A Multifunctional anti virus lozenge |
| 07/20/2005 | CN1640397A Kurarinol drop pill and its preparing method |
| 07/20/2005 | CN1640394A Andrographolide sulfonic acid sodium lyophilized powder for injection and its preparing method |
| 07/20/2005 | CN1211391C Crystal form of pifuadefuwei |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211381C Substituted imidazoles useful in treatment of inflammatory diseases |
| 07/20/2005 | CN1211375C Thiazole-derivatives |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211114C A compound Chinese herb composition, its preparation method and use |
| 07/20/2005 | CN1211112C Gubenhuiyuan traditional Chinese medicine composition and its method for producing oral liquid |
| 07/20/2005 | CN1211095C Blood pressure lowering and heart protectint tablet |
| 07/20/2005 | CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same |
| 07/20/2005 | CN1211084C Technology for producing Dekualinum lozenge |
| 07/20/2005 | CN1211063C Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919379 Compounds useful in reflux disease |
| 07/19/2005 | US6919378 Pharmaceutical solutions of modafinil compounds |
| 07/19/2005 | US6919371 Antidiabetic agents; dietetics; gastrointestinal disorders |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
| 07/19/2005 | US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919349 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919335 Heterocycles that are inhibitors of IMPDH enzyme |
| 07/19/2005 | US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919093 Formulation |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063725A1 Phenylpropanoic acid derivatives |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063271A1 Herbal composition for gastrointestinal disorders |
| 07/14/2005 | WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 07/14/2005 | WO2004069179A3 Improved thickened beverages for dysphagia |
| 07/14/2005 | WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154165 Ph-sensitive polymer |
| 07/14/2005 | US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis |
| 07/14/2005 | US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 07/14/2005 | US20050154031 which are selective against serotonin 5-HT2A and 5-HT2C receptors; 2-amino-5-methyl-4-(naphth-1-yl)thiazole; irritable bowel syndrome, dyspepsia, gastroesophageal reflux, tachygastria; migraine, neurogenic pain, anxiety, depression, sleep disorder, asthma, incontinence, endometriosis, and fibrosis |
| 07/14/2005 | US20050154028 1-(3-Fluoro-phenyl)-3-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-2-one; serotonin 5-ht2c receptor antagonist; antidepressant and anxiolytic agent |
| 07/14/2005 | US20050154026 Suitable for the treatment of gastric and intestinal disorders; in particular, omeprazole, rabeprazole, pantoprazole, esomeprazole |
| 07/14/2005 | US20050154025 6-[4-(fluoro- or trifluoromethyl)pyridyl-4-(p-fluorophenyl)-5-methylimidazol-2-yl] pyridones; cyclization of 1-phenyl-1-pyridyl-1,2-diaminopropanes with an acid, amidine, or nitrile compound; neuropeptide Y receptor antagonists; cardiovascular and central nervous system disorders, metabolic diseases |
| 07/14/2005 | US20050154019 Substituted cyclic amine metalloprotease inhibitors |
| 07/14/2005 | US20050154018 Method for treating and preventing disorders using optically pure (+) norcisapride |
| 07/14/2005 | US20050154015 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050154012 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050154007 Substituted imidazo[1,2-a]pyridines such as 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-6-methoxyimidazo[1,2-a]pyridine, used as antisectory agents for prophylaxis of gastrointestinal disorders |
| 07/14/2005 | US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition |
| 07/14/2005 | US20050153993 Treatment of statin side effects using uridine derivatives |
| 07/14/2005 | US20050153980 Substituted indoles |
| 07/14/2005 | US20050153978 Medicaments |